Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS System
1 other identifier
interventional
330
1 country
17
Brief Summary
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 5, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
July 1, 2026
June 1, 2026
2.2 years
June 5, 2026
June 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score
The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.
One year following study start up and initial assessment.
Study Arms (1)
QUILS Kentucky Coalition Initative
OTHERInterventions
Implementation initiative involving statewide coalition engagement surveys, interviews, educational outreach, and collaborative activities designed to improve awareness, coordination, policy support, and implementation of equitable and high-quality lung screening programs.
Eligibility Criteria
You may qualify if:
- Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.
- Willing to participate in the QUILS Index Assessment Survey process
- Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews
You may not qualify if:
- Unwilling to participate in the QUILS Index Assessment Survey process
- Unwilling to participate in the QUILS Audit Feedback presentations
- Unwilling to participate in formative evaluation interviews
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Timothy Mullettlead
Study Sites (17)
King's Daughter's Medical Center
Ashland, Kentucky, 41101, United States
Taylor Regional Hospital
Campbellsville, Kentucky, 42718, United States
St. Elizabeth Healthcare
Edgewood, Kentucky, 41017, United States
Georgetown Cancer Treatment Cancer
Georgetown, Kentucky, 40324, United States
TJ Samson Community Hospital
Glasgow, Kentucky, 42141, United States
Hazard Appalachian Regional Healthcare Medical Center
Hazard, Kentucky, 41701, United States
Lexington VA Health Care System
Lexington, Kentucky, 40502, United States
St. Joseph Health (Catholic Health Initiatives)
Lexington, Kentucky, 40504, United States
University of Kentucky Markey Cancer Center
Lexington, Kentucky, 40536, United States
The James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, 40202, United States
Meadowview Regional Medical Center
Maysville, Kentucky, 41056, United States
Saint Claire Regional Medical Center
Morehead, Kentucky, 40351, United States
Rockcastle Regional Hospital
Mount Vernon, Kentucky, 40456, United States
Owensboro Health Mitchell Memorial Cancer Center
Owensboro, Kentucky, 42303, United States
Mercy Health - Paducah Cancer Center
Paducah, Kentucky, 42003, United States
Lake Cumberland Regional Hospital
Somerset, Kentucky, 42501, United States
Clark Regional Medical Center
Winchester, Kentucky, 40391, United States
Study Officials
- STUDY CHAIR
Timothy W Mullett, MD
University of Kentucky
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 5, 2026
First Posted
June 10, 2026
Study Start
April 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
July 1, 2026
Record last verified: 2026-06